Industry

WALTHAM, Mass.–(BUSINESS WIRE)–#CardiacAblation—Thermedical®, a developer of thermal-ablation systems to treat ventricular arrhythmias, announced today that the U.S. Food & Drug Administration (FDA) has approved an open-label, single-arm interventional clinical trial to evaluate the safety and efficacy of the Thermedical® SERF Ablation System with the Durablate® Catheter in people with ventricular tachycardia (VT) resistant to conventional … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Europe Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type, Product Type, End User, Organization Size, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. The European pharmaceutical analytical testing outsourcing market was valued at $1,919.1 million in 2021 and will grow by 8.4% annually over 2021-2031, driven … [Read more…]

VANCOUVER, British Columbia–(BUSINESS WIRE)–Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating neurodegenerative disorders, today announced positive results from a bioequivalence study with ALPHA-1062, a proprietary, delayed release oral tablet formulation in development for the treatment of mild to moderate … [Read more…]

BURLINGAME, Calif.–(BUSINESS WIRE)–Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of La Jolla Pharmaceutical Company (Nasdaq: LJPC) (“La Jolla”) at a price of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type, Product Type, End User, Organization Size, and Region: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. The global pharmaceutical analytical testing outsourcing market will reach $16,527.5 million by 2031, growing by 8.4% annually over 2021-2031, driven by the increasing … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Sepsis Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product, Technology, Method, Test Type, Pathogen, and End User” report has been added to ResearchAndMarkets.com’s offering. The global sepsis diagnostics market is projected to reach US$ 1,226.52 million by 2028 from US$ 661.83 million in 2021; it is expected to … [Read more…]

Health system enters two-year national partnership to promote mental wellbeing and resiliency of first responders and frontline caregivers NASHVILLE, Tenn.–(BUSINESS WIRE)–HCA Healthcare, Inc. (NYSE: HCA), one of the nation’s leading healthcare providers, today announced a $600,000 grant to Volunteers of America (VOA) through the HCA Healthcare Foundation and its Healthier Tomorrow Fund to promote mental … [Read more…]

One of the largest manufacturing sites for the company, the $105 million facility adds capacity to enable more life-saving vaccines and therapies WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc., the world leader in serving science, today opened its largest single-use technology manufacturing site in Greater Nashville. The $105 million, 400,000-square-foot facility enables the company to help … [Read more…]

CSRI leaders are facilitating conversations about the health data utility model SAN ANTONIO–(BUSINESS WIRE)–#HIE–Leaders with the Consortium for State and Regional Interoperability (CSRI), a collection of the nation’s largest and most robust nonprofit health data networks, will drive dialogue about the health data utility model (thecsri.org/health-data-utility) at The Civitas 2022 Annual Conference, a Collaboration with … [Read more…]

CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today reported financial results for the second quarter ended June 30, 2022, and provided a corporate update. “We continue to make significant progress with advancing the clinical development of THIO. We recently dosed the first patient … [Read more…]